Increased circulating FGF21 level predicts the burden of metabolic demands and risk of vascular diseases in adults with type 2 diabetes
Liu Z, Peng Y, Li S, et al.
BMC Endocr Disord. 2023;23(1):272.
Leggi
Liu Z, Peng Y, Li S, et al.
BMC Endocr Disord. 2023;23(1):272.
Leggi
Igweokpala S, Sule NO, Douros A, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.
Leggi
Klein KR, Clemmensen KKB, Fong E, et al.
Diabetes Care. 2023:dc231791.
Leggi
Bantounou MA, Sardellis P, Thuemmler R, et al.
Diabetes Obes Metab. Pub. online 29 Nov 2023.
Leggi
Zupa MF, Vimalananda VG, Rothenberger SD, et al.
JAMA Netw Open. 2023;6(12):e2346305.
Leggi
The EMPA-KIDNEY Collaborative Group
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.
Leggi
Ray KK, Nicholls SJ, Li N, et al.
The Lancet Diabetes & Endocrinology. Pub. online 4 Dec 2023.
Leggi
Nayak A, Vakili S, Nayak K, et al.
JAMA Netw Open. 2023;6(12):e2340232.
Leggi
Nurizadeh F, Mohamadifard N, Nouri F, et al.
Nutrition, Metabolism and Cardiovascular Diseases. Pub. online 27 Nov 2023.
Leggi
Corpeleijn WE, de Waal WJ, Schipper HS, Wiegman A
Diabetologia. Pub. online 30 Nov 2023.
Leggi